Gene ID | Gene Symbol | Description | Source |
---|---|---|---|
948 | CD36 | CD36 molecule (CD36 blood group) | |
2147 | F2 | coagulation factor II, thrombin | |
3075 | CFH | complement factor H | |
3240 | HP | haptoglobin | |
3557 | IL1RN | interleukin 1 receptor antagonist | |
4153 | MBL2 | mannose binding lectin 2 | |
4179 | CD46 | CD46 molecule | |
5327 | PLAT | plasminogen activator, tissue type | |
6347 | CCL2 | C-C motif chemokine ligand 2 | |
7941 | PLA2G7 | phospholipase A2 group VII |
Gene ID | Gene Symbol | Description | Source |
---|---|---|---|
12491 | Cd36 | CD36 molecule | |
12628 | Cfh | complement component factor h | |
14061 | F2 | coagulation factor II | |
15439 | Hp | haptoglobin | |
16181 | Il1rn | interleukin 1 receptor antagonist | |
17082 | Il1rl1 | interleukin 1 receptor-like 1 | |
17195 | Mbl2 | mannose-binding lectin (protein C) 2 | |
17221 | Cd46 | CD46 antigen, complement regulatory protein | |
18791 | Plat | plasminogen activator, tissue | |
20296 | Ccl2 | C-C motif chemokine ligand 2 |
Gene ID | Gene Symbol | Description | Source |
---|---|---|---|
24464 | Hp | haptoglobin | |
24770 | Ccl2 | C-C motif chemokine ligand 2 | |
25556 | Il1rl1 | interleukin 1 receptor-like 1 | |
25692 | Plat | plasminogen activator, tissue type | |
29333 | Cd46 | CD46 molecule | |
60582 | Il1rn | interleukin 1 receptor antagonist | |
302499 | C1galt1c1 | C1GALT1-specific chaperone 1 |
Gene ID | Gene Symbol | Description | Source | Organism |
---|---|---|---|---|
448225 | c1galt1c1 | C1GALT1 specific chaperone 1 | Xenopus tropicalis (tropical clawed frog) | |
495031 | c1galt1c1.L | C1GALT1 specific chaperone 1 L homeolog | Xenopus laevis (African clawed frog) | |
108700090 | c1galt1c1.S | C1GALT1 specific chaperone 1 S homeolog | Xenopus laevis (African clawed frog) |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024